A case report of LAI two injection start in a 16-year-old adolescent with severe manic episode and comorbid cannabinoid use disorder

Asian J Psychiatr. 2024 Mar 4;94:103992. doi: 10.1016/j.ajp.2024.103992. Online ahead of print.ABSTRACTThere is a lack of randomized clinical trials and few studies regarding long-acting injectable antipsychotics (LAIs) in adolescents. Non-adherence, aggressiveness, comorbid substance use disorder and lack of insight may represent the main reasons for starting LAIs. Hereby we describe a 16-year-old male adolescent subject with bipolar type I disorder and comorbid cannabinoid use disorder, successfully treated with two-injection start regimen of LAI aripiprazole. Two-injection start regime of aripiprazole could represent an effective and safe therapeutic option for adolescents with early onset bipolar disorder.PMID:38461611 | DOI:10.1016/j.ajp.2024.103992
Source: Asian Journal of Psychiatry - Category: Psychiatry Authors: Source Type: research